Boothbay Fund Management, LLC Novo Nordisk A S Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

A detailed history of Boothbay Fund Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 66,272 shares of NVO stock, worth $5.79 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

66,272

Previous 38,374 72.7%

Holding current value

$5.79 Million

Previous $5.48 Million 44.08%

% of portfolio

0.22%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $3.32 Million - $4.06 Million	27,898 Added 72.7%	66,272 $7.89 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $2.28 Million - $2.73 Million	-18,589 Reduced 32.63%	38,374 $5.48 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $3.71 Million - $4.94 Million	36,368 Added 176.59%	56,963 $7.31 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $1.21 Million - $1.46 Million	13,820 Added 203.99%	20,595 $2.13 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $393,952 - $864,407	4,332 Added 177.32%	6,775 $616,000
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $170,486 - $188,706	-1,093 Reduced 30.91%	2,443 $395,000
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $1.55 Million - $1.87 Million	-11,742 Reduced 76.86%	3,536 $562,000
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $3.65 Million - $4.82 Million	-35,605 Reduced 69.97%	15,278 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.23 Million - $2.74 Million	-23,424 Reduced 31.52%	50,883 $5.07 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $1.1 Million - $1.3 Million	10,642 Added 16.72%	74,307 $8.28 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $1.72 Million - $2.08 Million	18,524 Added 41.04%	63,665 $7.07 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $2.17 Million - $2.65 Million	22,669 Added 100.88%	45,141 $5.06 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $1.9 Million - $2.4 Million	22,472 New	22,472 $2.16 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $218,677 - $273,944	-3,232 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $216,737 - $245,050	3,232 New	3,232 $218,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $255,468 - $296,490	-4,364 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $215,843 - $282,699	4,364 New	4,364 $263,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Novo Nordisk A S Transaction History